A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer

International Journal of Cancer

Volumn 102, Issue 5, 2002, Pages 536-540

  Zhu, Yong ^a   Spitz, Margaret R ^a   Strom, Sara ^a   Tomlinson, Gail E ^b   Amos, Christopher I ^b   Minna, John D ^b   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chromosome 9; Family history of cancer; FISH; Lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CASE CONTROL STUDY; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 9; ETHNIC GROUPS; FAMILY HEALTH; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; SMOKING;

EID: 0037058709     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10762     Document Type: Article

References (24)

1. Pathak S. Goodacre A. Specific chromosome anomalies and predisposition to human breast, renal cell, and colorectal carcinomas. Cancer Genet Cytogenet 1986;19:29-36.
2. Herrara L, Kakati S, Gibas L, Pietrazak E, Sandberg AA. Brief clinical report: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986;25:473-6.
3. Yunis JJ, Ramsay N. Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child 1978;132:161-3.
4. Yunis JJ, Ramsay N. Familial occurrence of the aniridia Wilms' tumor syndrome with deletion 11p13-14.1. J Pediatr 1980;96:102-730.
5. Lee WH, Bookstein R, Hong F, Young LH, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 1987;235:1394-9.
6. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990;60:509-20.
7. Pathak S, Dhaliwal MK, Hopwood VL. Genetic susceptibility, somatic mosaicisms and predisposition to human cancer. Anticancer Res 1989:9:17-20.
8. Lukeis R, Irving L, Garson M, Hasthorpe S. Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities. Genes Chromosomes Cancer 1990;2:116-24.
9. Zhou JY, Taguchi T, Siegfried JM, Jhanwar SC, Resau J, Testa JR. Characterization of 9q;15q whole-arm translocation derivatives in non-small cell lung carcinomas by fluoresence in situ hybridization. Cancer Genet Cytogenet 1993;69:1-6.
10. Merlo A, Gabrielson E, Askin F, Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-2.
11. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK, Mao L. Identification of 3 distinct tumor suppressor loci on the short arm of chromosome 9 in small lung cancer. Cancer Res 1997;57:400-3.
12. Suzuki K, Ogura T, Yokose T, Nagai K, Mukai K, Kodama T, Nishiwaki Y, Esumi H. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int J Cancer 1998;79:384-9.
13. Takamochi K, Ogura T, Suzuki K, Kawasaki H, Kurashima Y, Yokose T, Ochiai A, Nagai K, Nishiwaki Y, Esumi H. Loss of heterozygosity on chromosome 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol 2001;159:1941-8
14. INK4a in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer 2001;32:119-25.
15. Sanchez-Cespedes M, Decker PA, Doffek KM, Esteller M, Westra WH, Alawi EA, Herman JG, Demeure MJ, Sidransky D, Ahrendt SA. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res 2001;61:2092-6.
16. Dave BJ, Hopwood VL. King TM, Ziang H, Spitz MR, Pathak S. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev 1995;4:743-9.
17. Sundareshan TS, Augustus M. Expression of fragile sites in patients with retinoblastoma, their parents, and unaffected siblings: A study of ten families. Cancer Genet Cytogenet 1994;78:72-7.
18. Pathak S, Hopwood VL, Hortobagyi GN, Jackson GL, Hughes JI, Melillo D. Chromosome anomalies in human breast cancer: Evidence for specific involvement of 1q region in lymphocyte cultures. Anticancer Res 1991;11:1055-60.
19. Sundareshan TS, Augustus M. Expression of common fragile sites in lymphocytes of Wilms tumor in patients, their parents, and siblings: A study of ten families. Cancer Genet Cytogenet 1995;84:51-5.
20. Egeli U, Karadag MK, Tunca B, Ozyardimci. The expression of common fragile sites and genetic predisposition to squamous cell lung cancers. Cancer Genet Cytogenet 1997;95:153-8.
21. Hagmar L, Brogger A, Hansteen I, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I. Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 1994;54:2919-22.
22. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, Sbrana I, Vecchio D, et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 1995;79:133-5.
23. Park IW, Wistuba II, Maitra A, Milchgrub S, Virmani AK, Minna JD, Gazdar AF. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst 1999;91:1863-8.
24. Wu X, Lippman SM, Lee J, Zhu Y, Wei Q, Thomas M, Hong WK, Spitz MR. Chromosome instability in lymphocytes: A potential indicator of predisposition to oral premalignant lesions. Cancer Res 2002;62:2813-8.